Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)CVN058 Effect on Mismatch Negativity in Schizophrenics
- First Posted Date
- 2018-09-13
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- Cerevance Alpha, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT03669250
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
🇺🇸New York State Psychiatric Institute, New York, New York, United States
🇺🇸Nathan Kline Institute, New York, New York, United States
News
No news found